208710 — Biolog Device Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩44bn
- KR₩46bn
- KR₩106bn
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,645 | 6,585 | 4,198 | 10,945 | 2,917 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 33,496 | 21,368 | 26,437 | 25,248 | 31,219 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 42,415 | 35,741 | 36,280 | 42,401 | 42,037 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23,417 | 32,168 | 46,461 | 45,517 | 31,962 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 76,554 | 88,919 | 101,142 | 103,770 | 86,055 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 27,705 | 30,374 | 37,923 | 49,537 | 33,610 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 30,108 | 32,785 | 63,491 | 54,251 | 34,824 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 46,447 | 56,133 | 37,651 | 49,519 | 51,231 |
Total Liabilities & Shareholders' Equity | 76,554 | 88,919 | 101,142 | 103,770 | 86,055 |
Total Common Shares Outstanding |